Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of satraplatin in children and young adults with refractory solid tumors, including brain tumors, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • satraplatin (satraplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Brain Tumors | Phase 1 | Status: COMPLETED